Clinical Trial

Nd:YAG vs Alexandrite Laser Treatment in Hidradenitis Suppurativa

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate whether Alexandrite laser treatment is non-inferior to Nd:YAG (neodymium-doped yttrium aluminum garnet) laser treatment of hidradenitis suppurativa (HS).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-05; most recent amendment 2026-04-24.
Trial Details
NCT Number NCT06960447
Lead Sponsor Geisinger Clinic
Conditions Hidradenitis Suppurativa (HS)
Enrollment 21 participants
Start Date 2026-07
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-04-28